| P2093 | author name string | Joseph El Khoury | |
| | Suzanne E Hickman | |
| | Elizabeth K Allison | |
| | Nathan D Kingery-Gallagher | |
| | Uwanda Coleman | |
| P2860 | cites work | Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. | Q52549466 |
| | Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies | Q58780923 |
| | The CX3C chemokine fractalkine in allergic asthma and rhinitis | Q61895245 |
| | Microglia in neurodegeneration | Q91786444 |
| | The neuroimmune system in Alzheimer's disease: the glass is half full | Q28270052 |
| | Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease | Q28275105 |
| | A new class of membrane-bound chemokine with a CX3C motif | Q28303204 |
| | Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS | Q28570630 |
| | Amyloid precursor protein trafficking, processing, and function | Q29617429 |
| | Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion | Q29618089 |
| | Regulation of Tau Pathology by the Microglial Fractalkine Receptor | Q34179654 |
| | CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. | Q34254575 |
| | CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis | Q34796584 |
| | Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis | Q34828549 |
| | Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo | Q35023290 |
| | CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. | Q35213298 |
| | CD36 mediates the innate host response to beta-amyloid | Q36370903 |
| | Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice | Q37003128 |
| | Abeta-degrading enzymes in Alzheimer's disease. | Q37118130 |
| | The AbetaCs of Abeta-cleaving proteases | Q37250796 |
| | The microglial sensome revealed by direct RNA sequencing | Q37341692 |
| | Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential | Q37670253 |
| | Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine | Q40325740 |
| | Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamus | Q46684384 |
| | TGFβ directs gene expression of activated microglia to an anti‐inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes | Q47399868 |
| | Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease | Q48247414 |
| | Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. | Q48306292 |
| | Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/DeltaE9 mice | Q48521428 |
| | Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins | Q48601563 |
| | Co-expression of multiple transgenes in mouse CNS: a comparison of strategies | Q48889458 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | heterozygosity | Q124059385 |
| | microglia | Q1622829 |
| P304 | page(s) | 2780 | |
| P577 | publication date | 2019-12-02 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice | |
| P478 | volume | 10 | |